Uploaded December 2025 | Updated September 2026, 20 hours ago
For over thirty years, the Centers for Disease Control and Prevention (CDC) recommended administering the hepatitis B vaccine to all newborns, resulting in a significant reduction — approximately 95% — in pediatric hepatitis B infections in the United States.
Recently, the CDC’s Advisory Committee on Immunization Practices has updated its guidelines to recommend the vaccine only for infants born to mothers who are hepatitis B positive or whose status is unknown.
At Oregon Health & Science University, we remain committed to prioritizing patient health by adhering to the latest scientific evidence and public health standards related to vaccine safety and efficacy. Learn more with our Q&A at bit.ly/493HDD3
For over thirty years, the Centers for Disease Control and Prevention (CDC) recommended administering the hepatitis B vaccine to all newborns, resulting in a significant reduction — approximately 95% — in pediatric hepatitis B infections in the United States.
Recently, the CDC’s Advisory Committee on Immunization Practices has updated its guidelines to recommend the vaccine only for infants born to mothers who are hepatitis B positive or whose status is unknown.
At Oregon Health & Science University, we remain committed to prioritizing patient health by adhering to the latest scientific evidence and public health standards related to vaccine safety and efficacy. Learn more with our Q&A at bit.ly/493HDD3
